Status:
COMPLETED
HeartLinc, a Study With AMI Patients Undergoing PCI
Lead Sponsor:
Firalis SA
Conditions:
AMI Patients
Eligibility:
All Genders
18+ years
Brief Summary
HeartLinc is a non-interventional patient study to demonstrate medical utility of the lncRNA to predict HF in AMI patients. 300 patients are expected to be recruited.
Detailed Description
The recruiting phase of the study includes the recruitment of patients (36 months) and is followed by 12 month of monitoring for each patient. After deciding MI and PCI treatment by physical exam, ECG...
Eligibility Criteria
Inclusion
- Patients over 18 years
- Myocardial infarction in association with a recent acute coronary syndrome \<24 hrs leading to a coronary angioplasty decision
- Myocardial infarction with ST-elevation (STEMI) or myocardial infarction following acute coronary syndrome without ST-segment shift with a significant elevation of non-ST troponin (NSTEMI)
- Participation in the Hearlink Cohort
- Collecting and signed informed consent for Heartlink study participation and consent to participate in the ancillary Heartlink 2 study
Exclusion
- Sudden Cardiac arrest which resulted in resuscitation other than single, non-repeated electric shock,
- cardiogenic shock
- Severe extra-cardiac diseases involving the short-term life expectancy of patients (risk of death at one year
- Programmed major non-cardiac surgery
- Known Altered Left Ventricular function before Acute Coronary Syndrome inclusion
- History of left, right or global heart failure
- Significant heart failure at hospital admittance (KILLIP 2)
- Acute Coronary Syndrome know more than 24 hours
- History of Myocardial infarction
- Participation in any other in progress or stopped study for less than 3 months other than the Heartlink study
Key Trial Info
Start Date :
March 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT03322436
Start Date
March 13 2018
End Date
October 31 2022
Last Update
May 23 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de TOULOUSE
Toulouse, France, 31059
2
SNUH
Seoul, South Korea